272 related articles for article (PubMed ID: 15907524)
1. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
[TBL] [Abstract][Full Text] [Related]
3. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
4. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
5. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
6. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.
Breccia M; Avvisati G; Latagliata R; Carmosino I; Guarini A; De Propris MS; Gentilini F; Petti MC; Cimino G; Mandelli F; Lo-Coco F
Leukemia; 2007 Jan; 21(1):79-83. PubMed ID: 16932337
[TBL] [Abstract][Full Text] [Related]
8. Open issues on bleeding and thrombosis in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005
[TBL] [Abstract][Full Text] [Related]
9. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
10. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
[TBL] [Abstract][Full Text] [Related]
11. [Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid].
Medvedeva NA; Cherepanova VV; Tarasova LN; Kudriavtseva AV; Kostin AI; Kolupaeva OR
Ter Arkh; 2000; 72(7):27-31. PubMed ID: 10983317
[TBL] [Abstract][Full Text] [Related]
12. Bleeding and thrombosis in acute promyelocytic leukemia.
Choudhry A; DeLoughery TG
Am J Hematol; 2012 Jun; 87(6):596-603. PubMed ID: 22549696
[TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
14. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
Rickles FR; Falanga A; Montesinos P; Sanz MA; Brenner B; Barbui T
Thromb Res; 2007; 120 Suppl 2():S99-106. PubMed ID: 18023721
[TBL] [Abstract][Full Text] [Related]
15. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
Bai Y; Shi M; Yang X; Zhang W; Yang R; Wei X; Wei X; Duan L; Wang C; Mi R; Waqas Ahmed HA; Huo L; Chen Y; Xu F; Wu D; Sun K
Leuk Res; 2019 Apr; 79():34-37. PubMed ID: 30831481
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia-associated thrombosis.
Chang H; Kuo MC; Shih LY; Wu JH; Lin TL; Dunn P; Tang TC; Hung YS; Wang PN
Acta Haematol; 2013; 130(1):1-6. PubMed ID: 23343825
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience.
Grisariu S; Spectre G; Kalish Y; Gatt ME
Eur J Haematol; 2013 May; 90(5):397-403. PubMed ID: 23414485
[TBL] [Abstract][Full Text] [Related]
18. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia.
Kankirawatana S; Veerakul G; Sanpakit K; Tanphaichitr VS; Akkabutr P; Suwantol L; Mahasandana C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S549-57. PubMed ID: 12403231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
